Neoadjuvant immune checkpoint inhibitors for muscle-invasive urothelial carcinoma: a systematic review and meta-analysis

Key Points

• This research aims to evaluate the effectiveness of neoadjuvant immune checkpoint inhibitors in treating muscle-invasive urothelial carcinoma.
• Conducted a systematic review of existing literature
• Performed a meta-analysis of relevant studies
• Included data on treatment outcomes and patient responses
• Findings indicate positive treatment outcomes with neoadjuvant immune checkpoint inhibitors
• Multiple studies support the efficacy of these interventions in muscle-invasive cases
• Results suggest potential for improved survival rates in patients